← Back to Search

Transition Intervention for Transitional Care

N/A
Waitlist Available
Led By Alicia Arbaje, MD, MPH, PhD
Research Sponsored by Johns Hopkins University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Older Adults
Can speak English or Spanish
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 30 days after hospital discharge
Awards & highlights

Study Summary

This trial is testing whether a bundle of interventions can improve safety for older adults during care transitions from the hospital to home health.

Eligible Conditions
  • Transitional Care
  • Frail Elderly
  • Home Health Care

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You are over a certain age, usually specified in the study's requirements.
Select...
You must be able to speak either English or Spanish.
Select...
This criterion is incomplete and requires more information to provide a summary. Could you please provide additional context?

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within 30 days after hospital discharge
This trial's timeline: 3 weeks for screening, Varies for treatment, and within 30 days after hospital discharge for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
ED visit use or re-hospitalization
Secondary outcome measures
Existence of Unresolved Medication Issues
Mortality within 30 days of hospital discharge

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Transition InterventionExperimental Treatment1 Intervention
We will implement a bundle of care transition safety resources with the assistance of home health coordinators at the study site. These resources include a link to a video about home health services, a caregiver assessment, a care task role assignment sheet, and a shopping list.
Group II: ControlActive Control1 Intervention
We will select other home health provider teams that provide care to similar populations to serve as concurrent controls. No interventions will be administered.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Transition Intervention
2021
N/A
~780

Find a Location

Who is running the clinical trial?

Johns Hopkins UniversityLead Sponsor
2,242 Previous Clinical Trials
14,815,876 Total Patients Enrolled
Agency for Healthcare Research and Quality (AHRQ)FED
397 Previous Clinical Trials
7,087,728 Total Patients Enrolled
1 Trials studying Transitional Care
100 Patients Enrolled for Transitional Care
Alicia Arbaje, MD, MPH, PhDPrincipal InvestigatorJohns Hopkins University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there current openings in this research trial for volunteers?

"As per clinicaltrials.gov, this trial is not currently seeking new applicants. The research was first published on April 7th 2022 and last updated 13 days later. Nevertheless, there are still 9 other studies actively recruiting patients at present."

Answered by AI
~261 spots leftby Mar 2025